Schneider Joel Solomon Zev 4
4 · Solid Biosciences Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Schneider Joel Solomon Zev
Chief Operating Officer
Transactions
- Award
Common Stock
[F1]2020-03-11+75,000→ 201,656 total
Footnotes (1)
- [F1]The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date.
Signature
/s/ by Lynette Herscha as attorney-in-fact for Joel Schneider|2020-03-13